SPLICE SWITCHING OLIGONUCLEOTIDES TARGETING PSEUDOEXONS

The present invention relates to a method for identifying splice switching oligonucleotides (SSOs) able to modulate expression of a target protein in a cell by promoting incorporation of a pseudoexon into the mature mRNA upon binding to the pre-mRNA in the region +9 to +39 downstream to the 5'...

Full description

Saved in:
Bibliographic Details
Main Authors PETERSEN, Ulrika Simone Spangsberg, ANDRESEN, Brage, BRUUN, Gitte, HOLM, Lise, DOKTOR, Thomas
Format Patent
LanguageEnglish
French
Published 04.08.2022
Subjects
BEER
BIOCHEMISTRY
CHEMISTRY
COMPOSITIONS THEREOF
CULTURE MEDIA
ENZYMOLOGY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
MICROBIOLOGY
MICROORGANISMS OR ENZYMES
MUTATION OR GENETIC ENGINEERING
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS
SPIRITS
VINEGAR
WINE
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to a method for identifying splice switching oligonucleotides (SSOs) able to modulate expression of a target protein in a cell by promoting incorporation of a pseudoexon into the mature mRNA upon binding to the pre-mRNA in the region +9 to +39 downstream to the 5' splice site of said pseudoexon. The invention also relates to SSO obtained by said method and uses thereof. La présente invention concerne un procédé d'identification d'oligonucléotides à commutation d'épissage (SSO) pouvant moduler l'expression d'une protéine cible dans une cellule en favorisant l'incorporation d'un pseudoexon dans l'ARNm mature lors de la liaison au pré-ARNm dans une région située entre +9 et +39 en aval du site d'épissage 5' dudit pseudoexon. L'invention concerne également le SSO obtenu par ledit procédé et ses utilisations.
Bibliography:Application Number: WO2022EP51790